Translator-ac-cohort1

Download

translator-ac-cohort1@lists.renci.org

September 2026

1 participants
2 discussions

Follow Up: A&C/ROVER Progress Call
by Kenmogne, Kelyne Noel 24 Sep '26

24 Sep '26

Hello A&C participants, Thanks for coming to yesterday's A&C Check-in. Below are a few reminders and follow-ups: 1. The next Planning Committee call is October 6 2. The next A&C/ROVER Progress call is October 7 (attendance is 'mandatory', there are some important updates we'd like to share with you all) 3. We're recirculating the Planning Committee sign-up sheet<https://docs.google.com/spreadsheets/d/1vNgycn0kkHo0e47vj03Q35LLGvrAPxiyF6V…>. * ACTION ITEM: Please sign up for 2 dates. This will give us a backup presenter for each date or allow for a second presentation when the agenda permits. Remember this is low pressure presentation to help you make strides in your project. 4. Reese is also gathering brief stories about how the Translator UI has directly impacted your research for NCATS leadership. * Examples could include * Discovering drugs or genes you hadn't previously considered, pursuing a new research direction or hypothesis based on query results, or ways the UI made your workflow more intuitive or efficient. Even a sentence or two is helpful. * NCATS leadership is particularly interested to learn: * Have you discovered interesting drugs or genes through Translator query results that you wouldn't have considered before? * Have any query results led you to pursue a new research direction or hypothesis? * Have you had any moments while using the UI where it felt intuitive or made your workflow smoother? * Here's a completely made-up example story, but you're welcome to share in whatever format is easiest for you: * I ran a smart query for "What drugs may impact conditions related to Wilson Disease?<https://ui.ci.transltr.io/results?bD1XaWxzb24gRGlzZWFzZSZpPU1PTkRPOjAwMTAyM…>" and was surprised to find NFE2L2 multiple times among the results. I hadn't considered a relationship between NFE2L2 and Wilson Disease before, but several drug results upregulated NFE2L2. I'll be taking a closer look at the relationship between NFE2L2 and phenotypes of Wilson Disease in Pathfinder queries next. * ACTION ITEM: Please send Translator stories or anecdotes to Reese via Slack or email at reeserosedesign(a)gmail.com<mailto:reeserosedesign@gmail.com> as soon as possible. You can also contact Reese with questions about the request or how the feedback will be shared. Best, Kelyne Noel (KK) MPH On Behalf of Translator ROVER WG

1 0

Reminder: A&C Help Desk Tomorrow + Opportunity to Present to the Planning Committee
by Kenmogne, Kelyne Noel 16 Sep '26

16 Sep '26

Dear A&C Participants, This is a friendly reminder that our A&C Help Desk will take place tomorrow, September 16, from 12:30 PM to 1:00 PM ET. We hope you can join us to discuss questions, challenges, project updates, or anything else related to your A&C activities. We are also still looking for volunteers interested in presenting or showcasing their A&C project to the Translator Planning Committee. This is a great opportunity to share your work with a broad audience of consortium leaders and members who can provide feedback, brainstorming support, and ideas for next steps. If you are interested, please sign up to present<https://docs.google.com/spreadsheets/d/1vNgycn0kkHo0e47vj03Q35LLGvrAPxiyF6V…>. The next presentation slot is: • Tuesday, September 22 from 2:45 PM to 3:00 PM ET Please note that the presentation itself should be brief, about 5 minutes, allowing the remainder of the time for discussion, feedback, and brainstorming with the Planning Committee. Whether your project is just getting started, actively underway, or at a key decision point, we encourage you to take advantage of this opportunity to gather input and ideas from the consortium community. We look forward to seeing you at the Help Desk tomorrow! Best regards, Kelyne Noel On Behalf of ROVER WG

1 1